Oncternal Therapeutics Statistics
Total Valuation
Cerence has a market cap or net worth of $470.88 million. The enterprise value is $600.51 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cerence has 43.32 million shares outstanding. The number of shares has increased by 3.75% in one year.
| Current Share Class | 43.32M |
| Shares Outstanding | 43.32M |
| Shares Change (YoY) | +3.75% |
| Shares Change (QoQ) | -16.05% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 77.61% |
| Float | 42.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 58.44 |
| PS Ratio | 1.62 |
| Forward PS | 1.84 |
| PB Ratio | 2.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.08 |
| P/OCF Ratio | 8.48 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 43.80, with an EV/FCF ratio of 14.39.
| EV / Earnings | n/a |
| EV / Sales | 2.44 |
| EV / EBITDA | 43.80 |
| EV / EBIT | 112.92 |
| EV / FCF | 14.39 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.39.
| Current Ratio | 1.77 |
| Quick Ratio | 1.31 |
| Debt / Equity | 1.39 |
| Debt / EBITDA | 10.08 |
| Debt / FCF | 5.20 |
| Interest Coverage | 0.46 |
Financial Efficiency
Return on equity (ROE) is -16.63% and return on invested capital (ROIC) is 0.81%.
| Return on Equity (ROE) | -16.63% |
| Return on Assets (ROA) | 0.51% |
| Return on Invested Capital (ROIC) | 0.81% |
| Return on Capital Employed (ROCE) | 1.00% |
| Revenue Per Employee | $175,676 |
| Profits Per Employee | -$18,406 |
| Employee Count | 1,400 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 49.59 |
Taxes
In the past 12 months, Cerence has paid $2.03 million in taxes.
| Income Tax | 2.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +330.16% in the last 52 weeks. The beta is 2.86, so Cerence's price volatility has been higher than the market average.
| Beta (5Y) | 2.86 |
| 52-Week Price Change | +330.16% |
| 50-Day Moving Average | 9.37 |
| 200-Day Moving Average | 9.19 |
| Relative Strength Index (RSI) | 66.14 |
| Average Volume (20 Days) | 2,008,127 |
Short Selling Information
The latest short interest is 9.02 million, so 20.82% of the outstanding shares have been sold short.
| Short Interest | 9.02M |
| Short Previous Month | 8.81M |
| Short % of Shares Out | 20.82% |
| Short % of Float | 21.17% |
| Short Ratio (days to cover) | 4.29 |
Income Statement
In the last 12 months, Cerence had revenue of $245.95 million and -$25.77 million in losses. Loss per share was -$0.60.
| Revenue | 245.95M |
| Gross Profit | 174.04M |
| Operating Income | 5.32M |
| Pretax Income | -23.74M |
| Net Income | -25.77M |
| EBITDA | 13.71M |
| EBIT | 5.32M |
| Loss Per Share | -$0.60 |
Full Income StatementBalance Sheet
The company has $79.13 million in cash and $216.99 million in debt, giving a net cash position of -$137.86 million or -$3.18 per share.
| Cash & Cash Equivalents | 79.13M |
| Total Debt | 216.99M |
| Net Cash | -137.86M |
| Net Cash Per Share | -$3.18 |
| Equity (Book Value) | 155.67M |
| Book Value Per Share | 3.60 |
| Working Capital | 82.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $54.54 million and capital expenditures -$12.80 million, giving a free cash flow of $41.74 million.
| Operating Cash Flow | 54.54M |
| Capital Expenditures | -12.80M |
| Free Cash Flow | 41.74M |
| FCF Per Share | $0.96 |
Full Cash Flow StatementMargins
Gross margin is 70.76%, with operating and profit margins of 2.16% and -10.48%.
| Gross Margin | 70.76% |
| Operating Margin | 2.16% |
| Pretax Margin | -9.65% |
| Profit Margin | -10.48% |
| EBITDA Margin | 5.57% |
| EBIT Margin | 2.16% |
| FCF Margin | 16.97% |
Dividends & Yields
Cerence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.75% |
| Shareholder Yield | -3.75% |
| Earnings Yield | -5.57% |
| FCF Yield | 9.02% |
Analyst Forecast
The average price target for Cerence is $10.20, which is -6.16% lower than the current price. The consensus rating is "Hold".
| Price Target | $10.20 |
| Price Target Difference | -6.16% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cerence has an Altman Z-Score of -1.09 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.09 |
| Piotroski F-Score | 5 |
